Skip to main content
NewslettersWatchlist

Sangamo Therapeutics(SGMO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2021 Conference Call and Webcast

Business Wire - Thu Feb 17, 2022

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its fourth quarter and full year 2021 financial results after the market closes on Thursday, February 24, 2022. The press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide business updates.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 2235808. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 2235808.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

globe investor
Hoka-owner Deckers’ shares breach $1,000 mark for the first time
Dr. Richard Ehrlich puts on his Hoka Stinson ATR trail running shoes in Caledon, Ontario, on Tuesday, December 23, 2014.
inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald
inside the market
Reminder: The Globe Investing Club wants your stock picks
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
market news
The close: Stocks rebound amid encouraging U.S. economic data
Traders work on the floor of the New York Stock Exchange during morning trading on May 17.
inside the market
What every Canadian investor needs to know today
Traders work on the floor of the New York Stock Exchange during morning trading on May 17, 2024 in New York City. Wall Street stocks opened little changed May 17 after pulling back from a record run where the Dow exceeded 40,000 points for the first time. Around 10 minutes into trading the Dow Jones Industrial Average was steady at 39,872.66. (Photo by ANGELA WEISS / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)
investment ideas
Bullish on Canadian National Railway Co.
Monica Rizk
globe investor
Nvidia’s split of soaring stock could boost retail investor appeal, Dow chances
A view of a Nvidia logo at their headquarters in Taipei, Taiwan May 31, 2023.
market news
The close: Stocks fall despite Nvidia boost as U.S. inflation concerns weigh; Dow sees worst drop since March 2023 on Boeing woes
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 16.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).